Is MDGL Resmetirom Data Superior to Previous NASH Data?
Last updated 1/12/2023 Summary: MDGL read out Phase 3 topline data on December 19, leading to a stock move of over +250%! Many other NASH...
Is MDGL Resmetirom Data Superior to Previous NASH Data?
ESPR Nexletol - Stock back after Clear Outcomes data?
Biopharma Pulse - 9/12-9/16 Week in Review
Free Biopharma Daily Pulse - 08/26/22
Biopharma Daily Pulse - 08/25/22
Biopharma Daily Pulse - 08/24/22
Biopharma Mid Morning Pulse - 08/23/22
Biopharma Daily Pulse - 08/22/22